Pharmacokinetics Study of DESF in Adults With Oral Allergy Syndrome

Clinical trial NCT06527937 · COMPLETED

Trial details

NCT number: NCT06527937
Sponsor: Aquestive Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Reaction

Start date: 2024-07-17
Primary completion: 2024-10-10
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.